Medical technology company Carl Zeiss Meditec AG (CZMWF.PK) reported Tuesday a higher EBIT, a key earnings metric, in its none months, boosted by increased revenues in all business areas and all regions.
For the nine months, earnings before interest and tax or EBIT increased to 88.6 million euros from last year's 75.7 million euros. Revenue climbed 13.6 percent from last year to 630.8 million euros.
Ludwin Monz, President and CEO, said, "In spite of an increasingly difficult situation in the global economy, we achieved a solid result, with double-digit revenue growth, and stick firmly to our revenue forecast for the year as a whole."
For fiscal 2012, the company continues to expect revenue between 830 million euros and 860 million euros, which would correspond to a growth corridor of 9 to 13 percent.
The company added that it is firmly adhering to its previously forecast target of an EBIT margin of 15 percent by 2015.
For comments and feedback: editorial@rttnews.com